Correction: Clinical efficacy and predictive factors of photodynamic therapy combined with recombinant mussel mucin repair dressing in treating post-inflammatory hyperpigmentation - Summary - MDSpire

Correction: Clinical efficacy and predictive factors of photodynamic therapy combined with recombinant mussel mucin repair dressing in treating post-inflammatory hyperpigmentation

  • By

  • Jianjun Nie

  • Zengmiao Hou

  • Peimei Zhou

  • Ya Zhang

  • Yonghong Lu

  • June 24, 2026

  • 0 min

Share

Objective:

Correction of errors in figures related to chemical compound labeling in a study on photodynamic therapy and recombinant mussel mucin dressing.

Approach:
  • Correction Details: Figures 7, 8, and 9 were updated to include detailed labels identifying the chemical compounds used in the study.
Key Findings:
  • Figures 7A and B, 8, and 9A were published without detailed labels.
  • The corrections do not affect the scientific results or conclusions of the article.
Interpretation:

The figures have been updated for clarity and completeness.

Limitations:
  • The figures themselves remain unchanged aside from the added labels.
Conclusion:

The original version of the article has been updated to correct labeling errors.

Sources:

Original Source(s)

Correction: Clinical efficacy and predictive factors of photodynamic therapy combined with recombinant mussel mucin repair dressing in treating post-inflammatory hyperpigmentation

  • by Jianjun Nie, Zengmiao Hou, Peimei Zhou, Ya Zhang, Yonghong Lu

  • June 24, 2026

Related Content

Spatial RNA velocity reveals cellular state transitions and prognostic markers in the melanoma microenvironment

Optimized nursing strategies for skin graft outcomes: a narrative review of current evidence

The therapeutic potential of natural products for pediatric psoriasis: targeting the immune microenvironment